Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Qingling Liu & Chengbin Lei. (2021) LINC01232 serves as a novel biomarker and promotes tumour progression by sponging miR-204-5p and upregulating RAB22A in clear cell renal cell carcinoma. Annals of Medicine 53:1, pages 2153-2164.
Read now
Read now
Articles from other publishers (3)
Mehrdad Hashemi, Elaheh Mohandesi Khosroshahi, Mehrnaz Kalhor Chegini, Maryam Abedi, Arash Matinahmadi, Yasaman Sotodeh Dokht Hosnarody, Mahdi Rezaei, Yalda Saghari, Eisa Fattah, Soheila Abdi, Maliheh Entezari, Noushin Nabavi, Mohsen Rashidi, Rasoul Raesi & Afshin Taheriazam. (2023) miRNAs and exosomal miRNAs in lung cancer: New emerging players in tumor progression and therapy response. Pathology - Research and Practice 251, pages 154906.
Crossref
Crossref
Dawei Cai, Zhongbao Zhou, Guangzhu Wei, Peishan Wu & Guangqi Kong. (2022) Construction and verification of a novel hypoxia-related lncRNA signature related with survival outcomes and immune microenvironment of bladder urothelial carcinoma by weighted gene co-expression network analysis. Frontiers in Genetics 13.
Crossref
Crossref
Maliheh Entezari, Maryam Ghanbarirad, Afshin Taheriazam, Mehrdokht Sadrkhanloo, Amirhossein Zabolian, Mohammad Ali Shekhi Beig Goharrizi, Kiavash Hushmandi, Amir Reza Aref, Milad Ashrafizadeh, Ali Zarrabi, Noushin Nabavi, Navid Rabiee, Mehrdad Hashemi & Saeed Samarghandian. (2022) Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling. Biomedicine & Pharmacotherapy 150, pages 112963.
Crossref
Crossref